BridgeMD
Contrast Strategy In Fenestrated EndoVascular Aneurysm Repair Randomized Control Trial
EU CTIS ID: 2025-521795-58-00
What this study is testing
To explore if a strategy aimed at reducing the exposure to iodine contrast medium, achieved by preferentially using carbon dioxide (CO2) to visualize arteries during FEVAR when possible, reduces the postoperative incidence of AKI following FEVAR of abdominal aortic aneurysms compared to the standard of care.
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- The subject has given their written consent to participate in the trial.
- Planned elective FEVAR of juxtarenal or pararenal aneurysm aortic aneurysm within six months, using a customized fenestrated endograft based on stainless steel stents and polyester graft.
- ≥ 18 years old
- For female participants in fertile age a negative pregnancy test is required followed by highly effective birth control methods after inclusion and until the termination of the trial.
You likely can't join if
- Severe COPD (Chronic Obstructive Pulmonary Disease)
- Current participation in other clinical interventional trials (registers and non-interventional studies are allowed)
- Pregnancy or breast feeding
- Mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of participation in the trial
- Known atrium‐ or ventricular septal defect with right‐left‐shunt
- Thyrotoxicosis
See the full eligibility criteria
- The subject has given their written consent to participate in the trial.
- Planned elective FEVAR of juxtarenal or pararenal aneurysm aortic aneurysm within six months, using a customized fenestrated endograft based on stainless steel stents and polyester graft.
- ≥ 18 years old
- For female participants in fertile age a negative pregnancy test is required followed by highly effective birth control methods after inclusion and until the termination of the trial.
- Severe COPD (Chronic Obstructive Pulmonary Disease)
- Current participation in other clinical interventional trials (registers and non-interventional studies are allowed)
- Pregnancy or breast feeding
- Mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of participation in the trial
- Known atrium‐ or ventricular septal defect with right‐left‐shunt
- Thyrotoxicosis
- Severe renal arteries atherosclerosis (≥ 50%) in any of the renal arteries
- Shaggy aorta
- Distal extension of the disease requiring iliac branch devices or hypogastric embolization/coverage
- Contrast agent allergy even if premedication is used
- FEVAR done with anaesthesia other than general anaesthesia
- Inflammatory or infective aneurysm
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.